Comparative effectiveness research is particularly important in oncology, where the cost of treatments is high, according to Andrew L. Pecora, MD. One approach to contain costs is to provide “rational care,” he adds, which means striking a balance between treating too much and too little.
One way to be more vigilant with costs is to be more selective about ordering tests. For example, PET scans are not helpful with immuno-therapeutics because seeing tumor growth can be alarming and does not change the treatment course. It is also important not to focus too much on the cost of the drug, says Pecora. If a more expensive drug results in fewer hospitalizations, it may provide more value and result in better outcomes.
The cost of therapy can be a barrier for patients, however. Gaining more knowledge regarding biomarkers will help oncologists know which patients are most likely to benefit from a particular therapy, he states. As more is learned, it will become easier to optimize utilization. Providing appropriate healthcare through precision medicine is affordable, Pecora adds.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Risk for Second Primary Melanoma Increases After Primary Melanoma Diagnosis as Men Age
March 28th 2024A population-based cohort study out of Norway has found that older men have a higher risk of developing second primary invasive melanoma following an initial primary melanoma, suggesting the benefits of increased surveillance in these patients.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
CMS released a final rule to help patients obtain Children’s Health Insurance Program (CHIP) coverage and issued a proposed rule to update Medicare payment policies and rates for inpatient rehabilitation facilities; debate over if gift card incentives are acceptable in health care marketing.
Read More